Literature DB >> 30193129

Studying Tumor-ReacTive T Cells: A Personalized Organoid Model.

Ugur Sahin1.   

Abstract

Recently in Cell, Dijkstra et al. (2018) introduced a tumor organoid/lymphocyte co-culture-based approach to expand and analyze tumor-specific T cell responses in a patient-specific manner. The platform is applicable for epithelial cancers and may have significant value for clinical translation of novel personalized immunotherapies.
Copyright © 2018. Published by Elsevier Inc.

Entities:  

Mesh：

Year:  2018        PMID： 30193129     DOI： 10.1016/j.stem.2018.08.015

Source DB:  PubMed          Journal:  Cell Stem Cell        ISSN： 1875-9777            Impact factor:   24.633


  5 in total

Review 1.  3D Tumor Models and Their Use for the Testing of Immunotherapies.

Authors:  Nicolas Boucherit; Laurent Gorvel; Daniel Olive
Journal:  Front Immunol       Date:  2020-12-10       Impact factor: 7.561

Review 2.  Scientific Validation and Clinical Application of Lung Cancer Organoids.

Authors:  Dahye Lee; Yoonjoo Kim; Chaeuk Chung
Journal:  Cells       Date:  2021-11-04       Impact factor: 6.600

3.  Generation of murine tumour-reactive T cells by co-culturing murine pancreatic cancer organoids and peripheral blood lymphocytes.

Authors:  Alberto D'Angelo; Kensuke Shibata; Masayuki Tokunaga; Makoto Furutani-Seiki; Stefan Bagby
Journal:  Biochem Biophys Rep       Date:  2022-10-09

Review 4.  The pivotal application of patient-derived organoid biobanks for personalized treatment of gastrointestinal cancers.

Authors:  Ya-Ya Yu; Yan-Juan Zhu; Zhen-Zhen Xiao; Ya-Dong Chen; Xue-Song Chang; Yi-Hong Liu; Qing Tang; Hai-Bo Zhang
Journal:  Biomark Res       Date:  2022-10-08

Review 5.  Emerging organoid models: leaping forward in cancer research.

Authors:  Han Fan; Utkan Demirci; Pu Chen
Journal:  J Hematol Oncol       Date:  2019-12-29       Impact factor: 17.388
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.